Table 1.
Association of 24 SNPs of LOXL1 in Caucasian Patients with ES and Control Subjects
SNP | Chromosomal Position* | Minor Allele | Minor Allele Frequency |
P† | Padjusted‡ | Padjusted§ | OR (95% CI) | ||
---|---|---|---|---|---|---|---|---|---|
ES | EG | Controls | |||||||
rs12914489 | 71974990 | A | 0.147 | 0.145 | 0.071 | 0.0006 | 0.017 | 0.04 | 2.27 (1.41–3.66) |
rs8029844 | 71980525 | T | 0.031 | 0.035 | 0.028 | 0.76 | 1.14 (0.50–2.62) | ||
rs55736920 | 71982067 | T | 0.173 | 0.167 | 0.136 | 0.15 | 1.33 (0.90–1.97) | ||
rs34894704 | 71982575 | A | 0.133 | 0.130 | 0.202 | 0.0097 | 0.61 (0.41–0.89) | ||
rs4886467 | 71985866 | T | 0.415 | 0.404 | 0.535 | 0.0008 | 0.22 | 0.96 | 0.62 (0.46–0.82) |
rs62004863 | 71987041 | C | 0.111 | 0.120 | 0.068 | 0.034 | 1.71 (1.04–2.83) | ||
rs12914677 | 71988982 | G | 0.368 | 0.367 | 0.460 | 0.009 | 0.68 (0.51–0.91) | ||
rs4558370 | 71991963 | T | 0.080 | 0.074 | 0.162 | 0.0005 | 0.87 | 0.34 | 0.45 (0.28–0.71) |
rs4461027 | 71998601 | C | 0.604 | 0.596 | 0.426 | 8.2 × 10−7 | 0.17 | 0.72 | 2.04 (1.54–2.78) |
rs4886761 | 72002604 | T | 0.521 | 0.511 | 0.391 | 0.0002 | 0.25 | 0.72 | 1.70 (1.28–2.25) |
rs8026259 | 72003812 | C | 0.247 | 0.269 | 0.196 | 0.082 | 1.35 (0.96–1.89) | ||
rs16958477 | 72005519 | A | 0.580 | 0.573 | 0.403 | 6.4 × 10−7 | 0.60 | 0.47 | 2.05 (1.54–2.72) |
rs1048661‖ | 72006599 | T | 0.160 | 0.153 | 0.271 | 0.0003 | 0.99 | N/A | 0.51 (0.35–0.74) |
rs3825942‖ | 72006635 | A | 0.010 | 0.007 | 0.189 | 5.6 × 10−17 | 0.018 | N/A | 0.04 (0.02–0.12) |
rs2165241‖ | 72009255 | T | 0.785 | 0.783 | 0.469 | 9.4 × 10−20 | 0.25 | 0.05 | 4.17 (3.03–5.56) |
rs2304719 | 72022553 | T | 0.065 | 0.071 | 0.290 | 4.2 × 10−16 | 0.43 | 0.31 | 0.17 (0.11–0.27) |
rs1530169 | 72024173 | T | 0.180 | 0.158 | 0.237 | 0.051 | 0.71 (0.50–1.00) | ||
rs4243042 | 72028677 | T | 0.253 | 0.241 | 0.538 | 6.2 × 10−16 | 0.94 | 0.13 | 0.29 (0.21–0.39) |
rs2304722 | 72028802 | C | 0.008 | 0.007 | 0.003 | 0.30 | 3.11 (0.32–30.04) | ||
rs12437465 | 72030299 | T | 0.174 | 0.172 | 0.437 | 1.3 × 10−15 | 0.83 | 0.32 | 0.27 (0.20–0.38) |
rs12441138 | 72030950 | A | 0.039 | 0.032 | 0.043 | 0.81 | 0.92 (0.45–1.86) | ||
rs8818 | 72031331 | C | 0.171 | 0.167 | 0.236 | 0.026 | 0.67 (0.47–0.95) | ||
rs7173049 | 72031663 | G | 0.130 | 0.123 | 0.231 | 0.0002 | 0.80 | 0.65 | 0.50 (0.34–0.72) |
rs10152898 | 72042174 | T | 0.206 | 0.200 | 0.135 | 0.0099 | 1.66 (1.13–2.43) |
Base pair position in NCBI build 36.3 (National Center for Biotechnology Information, Bethesda, MD).
χ2 test. The Bonferroni corrected significance level was 0.0021 (0.05/24). Significant SNPs are highlighted in bold.
Logistic regression after adjustment for age and all the other 12 significant SNPs. The Bonferroni corrected significance level was 0.0038 (0.05/13).
Logistic regression after adjusting for age, rs1048661 and rs3825942. The Bonferroni-corrected significance level was 0.0038 (0.05/13). N/A, not applicable.
Significant association with ES has been reported in our previous study of a subgroup of samples.4